NCT00706771 - Bicarbonate and Lipocalin in Systemic Inflammatory Response Syndrome (SIRS) Study | Biotech Hunter

Enrollment

Participants

Timeline

Start Date

February 28, 2010

Primary Completion Date

September 30, 2012

Study Completion Date

September 30, 2012

Conditions

Systemic Inflammatory Response SyndromeOliguriaRenal Impairment

Interventions

DRUG

Sodium bicarbonate

Sodium bicarbonate: loading dose of 0.5 mmol/Kg and then continuous infusion of 0.2 mmol/Kg/hr

DRUG

Sodium chloride

0.9% sodium chloride: loading dose of 0.5 mmol/Kg and then continuous infusion of 0.2 mmol/Kg/hr

Trial Locations (2)

Austin Hospital, Heidelberg, Melbourne

Royal Melbourne Hospital, Melbourne